Passive immunization with human anti-protein D antibodies induced by polysaccharide protein D conjugates protects chinchillas against otitis media after intranasal challenge with Haemophilus influenzae. 2006

Laura A Novotny, and Joseph A Jurcisek, and Fabrice Godfroid, and Jan T Poolman, and Philippe A Denoël, and Lauren O Bakaletz
Columbus Children's Research Institute, Center for Microbial Pathogenesis, The Ohio State University College of Medicine and Public Health, 700 Children's Drive, W591, 43205, USA.

Passive transfer of a pediatric human serum pool generated against polysaccharide-protein D conjugate vaccines conferred approximately 34% protection against development of ascending NTHI-induced OM when used in a chinchilla viral-bacterial co-infection model. These data are in line with results obtained using a similar 11-valent-protein D conjugate vaccine in a pediatric clinical trial, wherein a vaccine efficacy of 35.6% was shown against acute OM episodes caused by NTHI. These observations strongly support the chinchilla passive transfer-superinfection model as one that could predict clinical trials outcomes for vaccines to prevent NTHI-induced OM.

UI MeSH Term Description Entries
D007072 Immunoglobulin D An immunoglobulin which accounts for less than 1% of plasma immunoglobulin. It is found on the membrane of many circulating B LYMPHOCYTES. IgD,IgD1,IgD2
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D009305 Nasopharynx The top portion of the pharynx situated posterior to the nose and superior to the SOFT PALATE. The nasopharynx is the posterior extension of the nasal cavities and has a respiratory function. Rhinopharynx,Choanae,Nasopharynges,Nasopharynxes,Rhinopharynges,Rhinopharynxes
D010033 Otitis Media Inflammation of the MIDDLE EAR including the AUDITORY OSSICLES and the EUSTACHIAN TUBE. Middle Ear Inflammation,Inflammation, Middle Ear
D011135 Polysaccharides, Bacterial Polysaccharides found in bacteria and in capsules thereof. Bacterial Polysaccharides
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002682 Chinchilla A genus of the family Chinchillidae which consists of three species: C. brevicaudata, C. lanigera, and C. villidera. They are used extensively in biomedical research. Chinchillas
D006193 Haemophilus influenzae A species of HAEMOPHILUS found on the mucous membranes of humans and a variety of animals. The species is further divided into biotypes I through VIII. Bacterium influenzae,Coccobacillus pfeifferi,Haemophilus meningitidis,Hemophilus influenzae,Influenza-bacillus,Mycobacterium influenzae

Related Publications

Laura A Novotny, and Joseph A Jurcisek, and Fabrice Godfroid, and Jan T Poolman, and Philippe A Denoël, and Lauren O Bakaletz
April 1996, Infection and immunity,
Laura A Novotny, and Joseph A Jurcisek, and Fabrice Godfroid, and Jan T Poolman, and Philippe A Denoël, and Lauren O Bakaletz
April 1995, Journal of immunology (Baltimore, Md. : 1950),
Laura A Novotny, and Joseph A Jurcisek, and Fabrice Godfroid, and Jan T Poolman, and Philippe A Denoël, and Lauren O Bakaletz
January 1995, American journal of otolaryngology,
Laura A Novotny, and Joseph A Jurcisek, and Fabrice Godfroid, and Jan T Poolman, and Philippe A Denoël, and Lauren O Bakaletz
November 1997, Infection and immunity,
Laura A Novotny, and Joseph A Jurcisek, and Fabrice Godfroid, and Jan T Poolman, and Philippe A Denoël, and Lauren O Bakaletz
February 2018, Vaccine,
Laura A Novotny, and Joseph A Jurcisek, and Fabrice Godfroid, and Jan T Poolman, and Philippe A Denoël, and Lauren O Bakaletz
January 2012, PloS one,
Laura A Novotny, and Joseph A Jurcisek, and Fabrice Godfroid, and Jan T Poolman, and Philippe A Denoël, and Lauren O Bakaletz
June 1999, Infection and immunity,
Laura A Novotny, and Joseph A Jurcisek, and Fabrice Godfroid, and Jan T Poolman, and Philippe A Denoël, and Lauren O Bakaletz
August 2012, FEMS immunology and medical microbiology,
Laura A Novotny, and Joseph A Jurcisek, and Fabrice Godfroid, and Jan T Poolman, and Philippe A Denoël, and Lauren O Bakaletz
May 1986, Infection and immunity,
Laura A Novotny, and Joseph A Jurcisek, and Fabrice Godfroid, and Jan T Poolman, and Philippe A Denoël, and Lauren O Bakaletz
July 2000, Vaccine,
Copied contents to your clipboard!